Get App Open
In App
Lending
Lending
Open App
you are here:

LIC MF Healthcare Fund - Regular Plan - IDCW

  • Regular
  • Direct
Category : Sectoral/Thematic
Fund House : IDBI Mutual Fund
  • NAV
    : ₹ 29.9326 0.47%
    (as on 16th October, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 97.83% investment in domestic equities of which 23.68% is in Large Cap stocks, 23.51% is in Mid Cap stocks, 7.88% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 15th October, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 08-Oct-25 10115.70 1.16% - 0.91% 129/239
1 Month 15-Sep-25 10026.80 0.27% - 0.35% 98/236
3 Month 15-Jul-25 9910.50 -0.90% - 0.57% 137/227
6 Month 15-Apr-25 10639.00 6.39% - 11.55% 199/224
YTD 01-Jan-25 9759.40 -2.41% - 2.97% 164/213
1 Year 15-Oct-24 9762.10 -2.38% -2.38% -1.87% 101/196
2 Year 13-Oct-23 15582.20 55.82% 24.72% 18.33% 16/152
3 Year 14-Oct-22 17381.10 73.81% 20.19% 19.92% 54/127
5 Year 15-Oct-20 19370.10 93.70% 14.13% 22.57% 94/103
Since Inception 28-Feb-19 29791.20 197.91% 17.89% 12.45% 54/212

SIP Returns (NAV as on 15th October, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 15-Oct-24 12000 12392.02 3.27 % 6.12 %
2 Year 13-Oct-23 24000 27733.72 15.56 % 14.57 %
3 Year 14-Oct-22 36000 48563.22 34.9 % 20.42 %
5 Year 15-Oct-20 60000 89305.79 48.84 % 15.9 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 30th Sep,2025)

Portfolio Turnover Ratio : 40.00%  |   Category average turnover ratio is 176.21%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 97.83% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 97.83%
No of Stocks : 29 (Category Avg - 44.42) | Large Cap Investments : 23.68%| Mid Cap Investments : 23.51% | Small Cap Investments : 7.88% | Other : 42.75%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 85.9 10.08% 0.35% 10.73% (May 2025) 9.72% (Aug 2025) 53.85 k 0.00
Apollo Hospitals Enterprises Ltd. Hospital 49.8 5.85% 0.05% 5.85% (Sep 2025) 2.91% (Nov 2024) 6.72 k 0.00
Torrent Pharmaceuticals Ltd. Pharmaceuticals 47.3 5.55% 0.26% 5.55% (Sep 2025) 4.91% (Oct 2024) 13.13 k 0.00
Cipla Ltd. Pharmaceuticals 46.9 5.51% -0.11% 5.62% (Aug 2025) 4.19% (Nov 2024) 31.22 k 0.00
Fortis Healthcare Ltd. Hospital 40.8 4.79% 0.45% 4.79% (Sep 2025) 0% (Oct 2024) 42.10 k 0.00
Piramal Pharma Ltd. Pharmaceuticals 37.9 4.45% 0.33% 7.55% (Oct 2024) 3.73% (Jul 2025) 1.98 L 0.00
Neuland Laboratories Ltd. Pharmaceuticals 35.3 4.14% 0.46% 4.24% (Nov 2024) 3.11% (Apr 2025) 2.41 k 0.00
Divis Laboratories Ltd. Pharmaceuticals 35 4.11% -0.16% 4.84% (May 2025) 3.92% (Dec 2024) 6.16 k 0.00
Aurobindo Pharma Ltd. Pharmaceuticals 33.9 3.98% 0.34% 4.57% (Apr 2025) 0% (Oct 2024) 31.30 k 0.00
Alkem Laboratories Ltd. Pharmaceuticals 33.7 3.96% 0.22% 3.96% (Sep 2025) 3.36% (Nov 2024) 6.21 k 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
TREPS TREPS 2.77%
Net Receivables Net Receivables -0.60%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)

  • Standard Deviation

    Low volatility
    12.12vs12.57
    Category Avg
  • Beta

    Low volatility
    0.64vs0.86
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    1.02vs1.01
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.19vs0.18
    Category Avg
  • Jensen's Alpha

    Better risk adjusted returns
    7.14vs3.66
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth NA 406.67 2.34 24.66 82.81 42.08 39.86
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth NA 266.19 0.39 9.43 25.89 25.50 19.25
Nippon India Japan Equity Fund - Growth NA 289.73 -1.32 11.93 18.11 15.99 18.46
Franklin Asian Equity Fund - Growth NA 279.13 1.52 9.83 26.06 15.33 15.42
SBI Banking & Financial Services Fund - Regular Plan - Growth NA 8693.07 2.95 1.72 12.07 14.17 20.29
DSP Banking & Financial Services Fund - Regular Plan - Growth NA 1419.62 2.84 1.42 10.44 13.24 0.00
ITI Banking and Financial Services Fund - Regular Plan - Growth NA 311.03 4.09 1.17 8.44 12.47 14.85
Motilal Oswal Business Cycle Fund - Regular Plan - Growth NA 1984.52 -1.20 2.41 13.61 12.47 0.00
Nippon India US Equity Opportunities Fund - Growth NA 724.35 -0.13 4.89 18.61 11.81 22.56
Mirae Asset Banking and Financial Services Fund - Growth NA 2014.27 3.39 0.89 10.03 11.54 19.00

More Funds from IDBI Mutual Fund

Out of 45 mutual fund schemes offered by this AMC, 2 is/are ranked 4 * , 10 is/are ranked 3 * , 10 is/are ranked 2 * , 5 is/are ranked 1 * , and 18 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
LIC MF Liquid Fund - Regular Plan - Growth 2 11402.57 0.48 1.40 2.96 6.66 6.96
LIC MF Money Market Fund - Regular Plan - Growth NA 3130.05 0.55 1.45 3.37 6.73 6.38
LIC MF Large & Mid Cap Fund - Growth 3 3046.84 0.14 -1.17 8.76 -3.61 16.82
LIC MF Nifty 8-13 yr G-Sec ETF NA 2248.29 0.72 0.57 2.44 8.22 9.10
LIC MF Nifty 8-13 yr G-Sec ETF NA 2248.29 0.71 0.52 2.37 8.04 8.89
LIC MF Banking & PSU Fund - Growth 3 1909.36 0.87 1.21 3.31 7.84 7.53
LIC MF Multi Cap Fund - Regular Plan - Growth NA 1715.77 0.88 1.09 13.51 -1.21 0.00
LIC MF Low Duration Fund - Growth 3 1705.18 0.58 1.38 3.23 7.14 6.91
LIC MF Low Duration Fund - Growth 3 1705.18 0.58 1.47 3.44 7.54 7.55
LIC MF Large Cap Fund - Growth 2 1445.32 0.05 -0.86 6.14 -1.37 12.69

Forum

+ See More